Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing. Abingworth LLP led the round.
Source: Press Release
Vera Therapeutics snags $80m Series C
Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: